Published Online:18 Jul 2006https://doi.org/10.2217/17460751.1.4.425
Abstract
Tissue engineering techniques for bladder regeneration have been applied successfully for many years in a variety of in vitro and in vivo models. But despite these rapid advances, to date, none of the tissue-engineered constructs could be used in human models due to inconsistent results of the described techniques in animal models. Three factors have been identified to influence the regeneration process: identification of the ideal scaffold, appropriate cell population for seeding and the optimal regeneration conditions necessary. Identifying the role of each component will help to unlock the complex regeneration mechanisms required to achieve consistent, reliable results that will allow transition of the technology into clinical practice. This review will discuss the role and applicability of the each factor and provide a future prospective on tissue engineering techniques for bladder regeneration.
Bibliography
- 1 Gerharz EW, Turner WH, Kaelble T, Woodhouse CRJ: Metabolic and functional consequences of urinary reconstruction with bowel. BJU91, 143–149 (2003).Crossref, Medline, CAS, Google Scholar
- 2 Kropp BP, Sawyer BD, Shannon HE et al.: Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J. Urol.156, 599–607 (1996).Crossref, Medline, CAS, Google Scholar
- 3 Kropp BP, Rippy MK, Badylak SF et al.: Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations. J. Urol.155, 2098–2104 (1996).Crossref, Medline, CAS, Google Scholar
- 4 Oberpenning F, Meng J, Yoo JJ, Atala A: De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. J. Urol.17, 149–155 (1999).CAS, Google Scholar
- 5 Shalhav AL, Elbahnasy AM, Bercowsky E et al.: Laparoscopic replacement of urinary tract segments using biodegrable materials in a large-animal model. J. Endourol.13, 241–244 (1999).Crossref, Medline, Google Scholar
- 6 Kropp BP, Cheng EY, Lin HK, Zhang Y: Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa. J. Urol. 172, 1710–1713 (2004).Crossref, Medline, Google Scholar
- 7 Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB: Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet367, 1241–1246 (2006).Crossref, Medline, Google Scholar
- 8 Kropp BP, Sawyer BD, Shannon HE et al.: Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J. Urol.156, 599 (1996).Crossref, Medline, CAS, Google Scholar
- 9 Raghavan D, Kropp BP, Lin HK, Zhang Y, Cowan R, Madihally SV: Physical characteristics of small intestinal submucosa scaffolds are location-dependent. J. Biomed. Mater. Res. A73, 90–96 (2005).Crossref, Medline, Google Scholar
- 10 Kropp BP, Badylak SF, Thor KB: Regenerative bladder augmentation: a review of the initial preclinical studies with porcine small intestinal submucosa. In: Muscle, Matrix and Bladder Function Zedric S (Ed.). Plenum Press, NY, USA, 229–235 (1995).Google Scholar
- 11 Zhang Y, Kropp BP, Moore P et al.: Coculture of bladder urothelial and smooth muscle cells on small intestinal submucosa: potential applications for tissue engineering technology. J. Urol.164, 928–935 (2000).Crossref, Medline, CAS, Google Scholar
- 12 Oberpenning F, Meng J, Yoo JJ, Atala A: De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol.17, 149–155 (1999).Crossref, Medline, CAS, Google Scholar
- 13 Lin HK, Cowan R, Moore P et al.: Characterization of neuropathic bladder smooth muscle cells in culture. J. Urol. 171, 1348–1352 (2004). Crossref, Medline, Google Scholar
- 14 Alison MR, Poulson R, Jeffery R et al.: Hepatocytes from non-hepatic stem cells. Nature406, 257 (2000).Crossref, Medline, CAS, Google Scholar
- 15 Orlic D, Kajstura J, Anversa P, et al.: Bone marrow cells regenerate infarted myocardium. Nature410, 701 (2001).Crossref, Medline, CAS, Google Scholar
- 16 Vogel G. Can adult stem cells suffice? Science292, 1820–1822 (2001).Crossref, Medline, CAS, Google Scholar
- 17 Chung SY, Krivorov NP, Rausei V et al.: Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J. Urol.174, 353–359 (2005).Crossref, Medline, Google Scholar
- 18 Zhang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int.96, 1120–1125 (2005).Crossref, Medline, CAS, Google Scholar
- 19 Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science282, 1145–1147 (1998).Crossref, Medline, CAS, Google Scholar
- 20 Shamblott MJ, Axelman J, Littlefield JW et al.: Human embryonic germ derivates express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl Acad. Sci.98, 113–118 (2000).Crossref, Google Scholar
- 21 Bishop AE, Buttery LDK, Polak JM: Embryonic stem cells. J. Pathol.197, 424–429 (2002).Crossref, Medline, Google Scholar
- 22 Xiong C, Xie CQ, Zhang L et al.: Derivation of adipocytes from human embryonic stem cells. Stem Cells14, 671–675 (2005).Crossref, CAS, Google Scholar
- 23 Kerr DA, Llado J, Shamblott MJ et al.: Human embryonic germ cell derivates facilitate motor recovery of rats with diffuse motor neuron injury. J. Neurosci.23, 5131–5140 (2003).Crossref, Medline, CAS, Google Scholar
- 24 Li Y, Powell S, Brunette E, Lebkowski J, Mandalam R: Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng.91, 688–698 (2005). Crossref, Medline, CAS, Google Scholar
- 25 Lakshmanan Y, Frimberger D, Gearhart JD, Gearhart JP: Human embryoid body-derived stem cells in co-culture with bladder smooth muscle and urothelium. Urology65, 821–826 (2005).Crossref, Medline, Google Scholar
- 26 Frimberger D, Morales N, Shamblott M, Gearhart JD, Gearhart JP, Lakshmanan Y: Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology65, 827–832 (2005).Crossref, Medline, Google Scholar
- 27 Frimberger D, Morales N, Gearhart JD, Gearhart JP, Lakshmanan Y: Human embryoid body-derived stem cells in tissue engineering – enhanced migration in co-culture with bladder smooth muscle and urothelium. Urology 67(6), 1298–1303 (2006).Crossref, Medline, Google Scholar
- 28 Snyder EY, Loring JF: Beyond fraud – stem-cell research continues. N. Engl. J. Med.354, 321–324 (2006).Crossref, Medline, CAS, Google Scholar
- 29 Arnold F, West DC. Angiogenesis in wound healing. Pharmacol. Ther.52, 407–422 (1991).Crossref, Medline, CAS, Google Scholar
- 30 Hippenstiel S, Krull M, Ikemann A, Risau W, Clauss M, Suttorp N: VEGF induces hyperpermeability by a direct action on endothelial cells. Am. J. Physiol.274, L678–L684 (1998).Medline, CAS, Google Scholar
- 31 Zhang F, Lei MP, Oswald TM et al.: The effect of vascular endothelial growth factor on the healing of ischaemic skin wounds. Br. J. Plast. Surg.56, 334–341(2003).Crossref, Medline, Google Scholar
- 32 Tufro A, Norwood VF, Carey RM, Gomez RA: Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J. Am. Soc. Nephrol.10, 2125–2134 (1999).Crossref, Medline, CAS, Google Scholar
- 33 Belgore F, Lip GY, Blann AD: Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur. J. Clin. Invest.33, 833–839 (2003).Crossref, Medline, CAS, Google Scholar
- 34 Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl Acad. Sci. USA83, 7297–7301 (1986).Crossref, Medline, CAS, Google Scholar
- 35 Yao C, Roderfeld M, Rath T, Roeb E, Bernhagen J, Steffens G: The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials27, 1608–1616 (2006).Crossref, Medline, CAS, Google Scholar
- 36 Pratsinis H, Giannouli CC, Zervolea I, Psarras S, Stathakos D, Kletsas D: Differential proliferative response of fetal and adult human skin fibroblasts to transforming growth factor-β. Wound Repair Regen.12, 374–383 (2004).Crossref, Medline, Google Scholar
- 37 Strutz F, Zeisberg M, Renziehausen A et al.: TGF-β 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int.59, 579–592 (2001).Crossref, Medline, CAS, Google Scholar
- 38 Vernon RB, Sage EH: A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc. Res.57, 118–133 (1999). Crossref, Medline, CAS, Google Scholar
- 39 Xue L, Greisler HP: Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system. Surgery132, 259–267 (2002). Crossref, Medline, Google Scholar
- 40 Tomanek RJ, Haung L, Suvarna PR, O’Brien LC, Ratajska A, Sandra A: Coronary vascularization during development in the rat and its relationship to basic fibroblast growth factor. Cardiovasc. Res.31, E116–E126 (1996). Crossref, Medline, CAS, Google Scholar
- 41 Tomanek RJ, Sandra A, Zheng W et al.: Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ. Res.88, 1135–1141 (2001).Crossref, Medline, CAS, Google Scholar
